0 0 Chemicalname=Biotinyl-Amyloid β-Protein (1-42),Biotinyl-Amyloid β-Protein (1-42),CAS=CAS=1802086-20-9Molecular formula=C213H325N57O62S2 | CLEARSYNTH

Biotinyl-Amyloid β-Protein (1-42)

DRUG PEPTIDES

Product Details

CAT No.# CS-AX-00011
Category Drug Peptides
CAS 1802086-20-9
Molecular Weight 4740.4
Molecular Formula C213H325N57O62S2
Purity: >98%
Synonyms: (3aS,4S,6aR)-4-[5-(alanylisoleucylvalylvalylglycylglycylvalylmethionylleucylglycylisoleucylisoleucylalanylglycyllysylasparagylserylglycylvalyl-α-aspartyl-α-glutamylalanylphenylalanylphenylalanylvalylleucyllysylglutamylhistidylhistidylvalyl-α-glutamyltyrosylglycylseryl-α-aspartylhistidylarginylphenylalanyl-α-glutamylalanyl-α-aspartyl)-5-oxopentyl]-hexahydro-1H-thieno[3,4-d]imidazol-2-one
Shipping: Free Shipping for worldwide on order above 2000 USD
Biotinyl-Amyloid β-Protein (1-42) Worldwide Suppliers of Biotinyl-Amyloid β-Protein (1-42) Drug Peptides Clearsynth CS-AX-00011

Product rating: 9 Biotinyl-Amyloid β-Protein (1-42) based on 20 ratings

  1. Drug Peptides
  2. Biotinyl-Amyloid β-Protein (1-42)

PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Crisaborole m-Isomer
15. Riluzole (1604337)
16. Pheniramine impurity B
17. Palbociclib N-Glucuronide
18. Carpropamid
19. Olmesartan N1-Trityl Impurity
20. Aripiprazole (1042634)




This page contains information about Biotinyl-Amyloid β-Protein (1-42) Cas 1802086-20-9 and its Drug Peptides.

Biotinyl-Amyloid β-Protein (1-42) Biotinyl-Amyloid β-Protein (1-42) Worldwide Suppliers of Biotinyl-Amyloid β-Protein (1-42) Drug Peptides Clearsynth 1802086-20-9

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."